Uzbekistan Opens 60-Day Fast Review for Ultrasound Metrics

On June 16, 2026, Uzbekistan’s pharmaceutical regulator UzPharm announced a fast-track pre-review route for certain Ultrasound Metrics devices, shortening the registration cycle from 180 calendar days to 60 for qualifying products. The change matters not only for manufacturers of B-mode ultrasound, portable ultrasound, and AI-assisted diagnostic modules, but also for distributors, procurement teams, compliance staff, and service providers that depend on registration timing, technical documentation, and market-entry planning.

A narrower registration window with defined technical conditions

According to the announced measure, the new “green channel” pre-review mechanism applies to Ultrasound Metrics equipment that meets ISO 13485 and IEC 62353 requirements. The covered categories are B-mode ultrasound, portable ultrasound, and AI-assisted diagnostic modules. UzPharm stated that the registration period under this route is 60 calendar days, compared with the previous 180 days, and that CE or NMPA registration certificates may be accepted as a basis for mutual recognition in technical documentation. The first pilot phase covers Tashkent and Samarkand.

Where the operational impact is most likely to appear

Manufacturers and exporters may see registration planning shift

From an industry perspective, the most immediate effect is on companies preparing market entry for the covered device categories. A shorter review cycle can change how exporters sequence dossier submission, shipment planning, and distributor coordination. What deserves closer attention is that the faster route is tied to specific standards and to the use of CE or NMPA registration certificates as a documentation basis, so eligibility and document readiness become central rather than optional issues.

Distributors and local channel partners may need tighter document control

For distributors and in-country partners, the announcement may affect onboarding schedules, launch timing, and stock planning in the pilot locations. Analysis shows that the practical pressure point is likely to be technical file consistency: if commercial teams assume that all ultrasound products can move faster without confirming whether they fall within the covered scope, they may face delays in contracting, customs preparation, or downstream customer commitments.

Healthcare buyers may adjust procurement timing, but not compliance thresholds

Hospitals, clinics, and other buyers in the pilot centers may pay closer attention to product availability and tender timing if registration can be completed in a shorter period. At the same time, the announcement should not be read as a relaxation of compliance expectations. Observably, the key change is the review pathway and documentation recognition basis, not the removal of technical or quality requirements.

Testing, certification, and after-sales teams may face earlier readiness demands

Companies involved in testing support, certification preparation, installation, and after-sales service may need to align earlier with product launch schedules. If a registration timeline compresses, supporting functions may have less room to resolve gaps in technical papers, service preparedness, or traceability records after a filing has already begun.

What companies should review now

Check whether the product clearly fits the announced scope

Companies should first verify whether their product falls within the stated categories of B-mode ultrasound, portable ultrasound, or AI-assisted diagnostic modules, and whether it is being presented in a way that matches the announced fast-track scope. This is especially important for products with mixed functions or software-linked diagnostic features.

Re-examine standards alignment and dossier structure

Analysis shows that ISO 13485 and IEC 62353 are not background references here; they are part of the stated entry conditions for the route. Companies should therefore review whether their technical documentation, certificates, and supporting materials are organized in a way that can support a fast pre-review process, especially where CE or NMPA registration certificates are intended to serve as the basis for document recognition.

Follow execution language in procurement and partner communications

Because the first phase is described as a pilot covering Tashkent and Samarkand, companies should watch how local procurement documents, distributor requests, and registration communications describe the route in practice. If no additional implementation detail has yet been provided, it is more appropriate to treat this as a live regulatory signal that still requires careful confirmation in execution.

Prepare for delivery and service obligations alongside faster approval

A shorter registration cycle may compress commercial timelines, but it can also expose weaknesses in supply continuity, installation readiness, and post-market support. Companies should review whether internal teams and local partners can support faster deployment without creating gaps in service records, product traceability, or customer handover documentation.

Why this looks like an execution signal, not a finished policy story

Observably, this announcement is more than a routine administrative update because it links review speed, recognized standards, and technical-document mutual recognition in one measure. At the same time, it is more appropriate to understand it as an execution-stage signal rather than a fully settled end state. Analysis shows that the market will still need to watch how the pilot is applied in practice, how consistently CE or NMPA-based documentation is handled, and whether follow-up guidance changes the working interpretation for filings, tenders, or partner qualification.

How the market may best read this change for now

At this stage, the measure can be read as a targeted easing of registration timing for defined ultrasound-related products, rather than as a broad reduction in compliance expectations. For the industry, the practical significance lies in the combination of a shorter review period, named standards, and document-recognition language. The most balanced reading is that companies with products already aligned to the stated requirements may gain a timing advantage, while everyone else still needs to watch implementation details before treating the route as predictable in every case.

Basis of this article and what still needs verification

This article is based on the user-provided news title, event date, and event summary. For developments of this kind, relevant source types typically include official regulatory announcements, releases from supervisory authorities, trade or customs-related notices, industry association updates, standards body documents, and reporting by authoritative sector media. A specific official source link was not provided in the input, so the underlying notice and any subsequent implementation details still need ongoing verification. What remains worth monitoring includes follow-up policy language, certification handling in practice, changes in tender or procurement documents, market feedback from pilot locations, and how companies execute filings and delivery under the new timeline.